Based on data from the past 90 days ending December 12, 2025, Revolution Medicines's three largest insider shareholders are Director Mark A Goldsmith (315.29K shares), Officer Stephen Michael Kelsey (284.05K shares), Chief Financial Officer Jack Anders (110.99K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Rock Ventures Iii, L.P. Third | 5,104,130 | 10 Jun, 2022 | |
| Alexis Borisy | 2,338,884 | 30 Jun, 2025 | |
| Peter Svennilson | 1,775,236 | 28 Apr, 2021 | |
| Thilo Schroeder | 760,869 | 09 Dec, 2024 | |
| Mark A Goldsmith | 315,287 | 26 Nov, 2025 | |
| Stephen Michael Kelsey | 284,047 | 15 Oct, 2025 | |
| Margaret A Horn | Chief Operating Officer | 145,900 | 18 Sep, 2025 |
| Jack Anders | Chief Financial Officer | 110,994 | 26 Nov, 2025 |
| Xiaolin Wang | 102,321 | 19 Mar, 2025 | |
| Sandra Horning | 96,574 | 30 Jun, 2025 | |
| Lin Wei | Chief Medical Officer | 88,339 | 18 Sep, 2025 |
| Lorence H. Kim | 73,090 | 30 Jun, 2025 | |
| Jeff Cislini | General Counsel | 50,425 | 20 Nov, 2025 |
| Elizabeth M Anderson | 26,990 | 30 Jun, 2025 | |
| Flavia Borellini | 25,024 | 30 Jun, 2025 | |
| Vincent A. Miller | 23,750 | 24 Jun, 2021 | |
| Sushil Patel | 23,090 | 30 Jun, 2025 | |
| Eric Thomas Schmidt | 21,251 | 12 Jun, 2023 | |
| Barbara Weber | 13,065 | 10 Oct, 2024 | |
| Frank Clyburn | 9,738 | 30 Jun, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 25 Nov, 2025 | Mark A Goldsmith | Common Stock | A | 60,000 | $4.09 | 307,863 | D | M |
| 25 Nov, 2025 | Jack Anders | Common Stock | A | 5,418 | $17.00 | 116,412 | D | M |
| 25 Nov, 2025 | Mark A Goldsmith | Common Stock | D | 60,000 | $75.08 | 247,863 | D | S |
| 25 Nov, 2025 | Jack Anders | Common Stock | D | 5,418 | $74.00 | 110,994 | D | S |
| 25 Nov, 2025 | Mark A Goldsmith | Common Stock | D | 3,000 | $75.00 | 67,424 | I | S |
| 25 Nov, 2025 | Mark A Goldsmith | Common Stock | D | 3,000 | $75.00 | 67,424 | I | S |
| 18 Nov, 2025 | Jeff Cislini | Common Stock | A | 13,388 | $42.45 | 63,813 | D | M |
| 18 Nov, 2025 | Mark A Goldsmith | Common Stock | A | 20,000 | $4.09 | 267,863 | D | M |
| 18 Nov, 2025 | Jeff Cislini | Common Stock | D | 13,388 | $70.14 | 50,425 | D | S |
| 18 Nov, 2025 | Mark A Goldsmith | Common Stock | D | 20,000 | $70.38 | 247,863 | D | S |
| 12 Nov, 2025 | Mark A Goldsmith | Common Stock | A | 20,000 | $4.09 | 267,863 | D | M |
| 12 Nov, 2025 | Mark A Goldsmith | Common Stock | D | 20,000 | $65.07 | 247,863 | D | S |
| 11 Nov, 2025 | Jack Anders | Common Stock | A | 10,000 | $17.00 | 120,994 | D | M |
| 11 Nov, 2025 | Jack Anders | Common Stock | D | 10,000 | $64.00 | 110,994 | D | S |
| 07 Nov, 2025 | Mark A Goldsmith | Common Stock | A | 26,479 | $1.12 | 374,342 | D | M |
| 07 Nov, 2025 | Mark A Goldsmith | Common Stock | A | 3,521 | $4.09 | 377,863 | D | M |
| 07 Nov, 2025 | Mark A Goldsmith | Common Stock | D | 30,000 | $60.31 | 347,863 | D | S |
| 12 Nov, 2025 | Mark A Goldsmith | Common Stock | D | 50,000 | $0.00 | 297,863 | D | G |
| 12 Nov, 2025 | Mark A Goldsmith | Common Stock | D | 50,000 | $0.00 | 247,863 | D | G |
| 12 Nov, 2025 | Mark A Goldsmith | Common Stock | A | 50,000 | $0.00 | 70,424 | I | G |